Literature DB >> 11209000

Ultrasound guided puncture of the brachial artery for haemodialysis fistula angiography.

K W Lui1, K M Yeow, Y L Wan, Y C Cheung, K K Ng, J H Tseng.   

Abstract

BACKGROUND: Arterio-venous (a-v) fistulae of haemodialysis patients frequently require function assessment by angiography. The purpose of the present study was to determine the efficacy and safety of ultrasound-guided transbrachial catheterization when a-v fistulae were evaluated.
METHODS: Between July 1996 and December 1997, 208 dialysis patients, whose a-v fistulae (arterial inflow < 50 ml/min or venous pressure > 150 mm Hg in three consecutive HD sessions) were at the wrist or elbow, underwent transbrachial angiography using an ultrasound-guided 20-gauge IA needle to evaluate fistula function. Procedure-related symptoms or complications were noted in 28 patients and these were analysed.
RESULTS: No apparent cases of vessel spasm or thrombosis were noted. Reported symptoms in 28 patients (13.5%) included local arm pain (3.3%), transient paresthesia (0.9%), mild ecchymosis (10.6%) and haematoma (0.9%). All complications were minor and none required surgical intervention.
CONCLUSION: Ultrasound-guided puncture of the brachial artery is a safe, reliable and effective procedure in skilled hands and should be the preferred means of catheterization whenever haemodialysis angiography is performed.

Entities:  

Mesh:

Year:  2001        PMID: 11209000     DOI: 10.1093/ndt/16.1.98

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

Review 1.  Ultrasound-guided arterial catheterization: a narrative review.

Authors:  Ariel L Shiloh; Lewis A Eisen
Journal:  Intensive Care Med       Date:  2009-10-31       Impact factor: 17.440

Review 2.  Imaging in Vascular Access.

Authors:  Eoin A Murphy; Rose A Ross; Robert G Jones; Stephen J Gandy; Nicolas Aristokleous; Marco Salsano; Jonathan R Weir-McCall; Shona Matthew; John Graeme Houston
Journal:  Cardiovasc Eng Technol       Date:  2017-07-13       Impact factor: 2.495

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.